Paola Arbour Sells 10,878 Shares of Tenet Healthcare (NYSE:THC) Stock

Tenet Healthcare Corporation (NYSE:THC) EVP Paola Arbour sold 10,878 shares of the stock in a transaction on Monday, July 27th. The shares were sold at an average price of $243.90, for a total value of $2,653,144.20. Following the transaction, the executive vice president directly owned 18,413 shares of the company’s stock, valued at approximately $4,490,930.70. The trade was a 37.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Tenet Healthcare Stock Down 2.0%

THC opened at $257.37 on Thursday. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. The company has a market capitalization of $22.17 billion, a PE ratio of 9.93, a P/E/G ratio of 1.02 and a beta of 1.27. The stock’s fifty day moving average is $188.99 and its 200-day moving average is $198.60. Tenet Healthcare Corporation has a one year low of $155.02 and a one year high of $262.68.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, beating the consensus estimate of $4.26 by $1.86. The business had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the business posted $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, equities analysts predict that Tenet Healthcare Corporation will post 20.62 EPS for the current fiscal year.

Trending Headlines about Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Strong earnings underpin the rally: Tenet’s latest quarterly results showed EPS of $6.12, well above the $4.26 consensus estimate, while revenue of $6.04 billion also exceeded expectations. Revenue increased 6.8% year over year, and the company raised its 2026 outlook, reinforcing confidence in operating performance and cost discipline. Tenet Healthcare earnings and outlook
• Positive Sentiment: Analysts raised price targets: Truist lifted its target to $290 from $270 and maintained a “buy” rating. Guggenheim raised its target to $283 from $242 and also rated the shares “buy.” Baird increased its target to $280 from $210, although it retained a neutral rating. The revisions reflect improved earnings expectations following Tenet’s results. Analyst price-target updates
• Positive Sentiment: Growth and momentum remain favorable: Zacks highlighted THC as a potentially attractive growth, value and momentum stock based on earnings estimates, estimate revisions and recent price strength. Tenet’s shares recently reached a 52-week high, which may continue to draw momentum-focused investors. Zacks growth analysis
• Neutral Sentiment: Valuation and consensus outlook: THC trades at roughly 10 times earnings, while 17 analysts rate the stock “buy” and three rate it “hold.” The average price target is approximately $268.50, suggesting analysts remain constructive but that much of the near-term upside may already be reflected in the share price. Zacks value analysis
• Negative Sentiment: Insider selling creates an overhang: EVP Paola M. Arbour sold 10,878 shares for about $2.65 million, reducing her holdings by 37.14%. Director Christopher Lynch sold 3,837 shares valued at approximately $934,000, cutting his position by 28.62%. The sales may be personal transactions, but their size could weigh on sentiment after the recent run-up. Tenet Healthcare insider filing

Hedge Funds Weigh In On Tenet Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Triumph Capital Management acquired a new stake in Tenet Healthcare during the 3rd quarter valued at $25,000. Activest Wealth Management acquired a new stake in shares of Tenet Healthcare in the fourth quarter worth $26,000. Elyxium Wealth LLC purchased a new position in shares of Tenet Healthcare during the fourth quarter valued at $29,000. Canada Pension Plan Investment Board acquired a new position in Tenet Healthcare during the second quarter valued at $35,000. Finally, Meeder Asset Management Inc. boosted its position in Tenet Healthcare by 146.2% during the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after acquiring an additional 114 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

Analysts Set New Price Targets

THC has been the topic of a number of research reports. Robert W. Baird boosted their target price on shares of Tenet Healthcare from $210.00 to $280.00 and gave the stock a “neutral” rating in a report on Tuesday. TD Cowen lifted their price target on shares of Tenet Healthcare from $233.00 to $263.00 and gave the stock a “buy” rating in a research report on Monday. UBS Group increased their price objective on Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a research report on Monday. Guggenheim lifted their target price on Tenet Healthcare from $242.00 to $283.00 and gave the stock a “buy” rating in a report on Tuesday. Finally, Morgan Stanley upped their target price on Tenet Healthcare from $254.00 to $274.00 and gave the company an “overweight” rating in a report on Monday. Seventeen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Tenet Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $268.50.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.